BRITS have been urged to look out for SIX early warning signs of skin cancer you should never ignore as Danielle Lloyd ...

In his first interview since his wife's death, Caden Hutchins tells TODAY.com about her early symptoms and positive attitude ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is currently ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

The company is on track to complete the interim data analysis before the end of Q1 2025 and to submit the findings to the U.S ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Researchers have discovered a new type of neuron that plays a fundamental role in recognition memory -- how the brain registers the difference between new and familiar objects and forms long-term ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Dr Scott Tagawa discusses how dose adjustments can optimize the use of enfortumab vedotin in urothelial cancer.

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).